Topic: irritability

AimsChallenging behaviours, such as aggression and irritability, are manifested by up to two thirds of autistic individuals. However, despite the detrimental effects challenging behaviours, particularly aggression, have on life of autistic individuals and their families, currently available treatment options are typically borrowed from other areas of psychiatry, and the FDA approved drugs for treatment of ASD-associated irritability are burdened with serious side effects. Therefore, in this study we investigated the effects of oxytocin, a neuropeptide with reported prosocial and anti-aggressiv

Substance use disorders (SUD) and aggressive behaviour often co-occur within individuals, along with transdiagnostic behavioural traits such as risk-taking behaviour, impulsivity, irritability, neuroticism, or anxiety. This study investigates shared genetic risk factors across these phenotypes using public genome-wide association study (GWAS) data: five GWAS on SUD, two on aggressive behaviour, and seven on related behavioural traits. We calculated genetic correlations and identified trait-specific associated SNPs shared between these phenotypes using Polarmorphism. Also, we determined how the